Other News To Note
Wednesday, July 31, 2013
Antitope Ltd., of Cambridge, UK, signed a research agreement with Faron Pharmaceuticals Ltd., of Turku, Finland, to generate therapeutic monoclonal antibodies against the Clever-1 receptor.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.